Endomárketing: Estrategia de innovación en las organizaciones el siglo XXI

Productivity, profitability and good organizational climate are the challenges that companies, regardless of their size, assume in this century. The permanent competitiveness has generated a tight business environment in the level of internal gear of the company is reflected in the positioning of the product or service that offers the same to the end customer. This is why managing to the interior of companies has taken on a role in generating innovative processes such as Endomarketing. This is a series of techniques directed and applied to the internal customers (employees) that create the permanent motivation towards the accomplishment of their daily tasks, the commitment and the end of the organization, to make the worker the first client, in the more faithful and The best reference that the final customer can find. This article proposes that Endomarketing is an effective strategy to improve organizational processes, internal customer satisfaction and business projection.Productividad, rentabilidad y buen clima organizacional son los retos que las empresas, sin importar su tamaño, asumen en este siglo. La competitividad permanente ha generado un ambiente empresarial reñido donde el nivel de engranaje interno de la empresa se refleja en el posicionamiento del producto o servicio que ofrece la misma al cliente final. Es por ello gestionar hacia el interior de las empresas ha tomado relevancia generando procesos innovadores como el Endomárketing. Este es una serie de técnicas dirigidas y aplicadas a los clientes internos (empleados) que crea motivación permanente hacia la realización de sus labores diarias, compromiso y lealtad con la organización, para lograr que el trabajador sea el primer cliente, en el más fiel y la mejor referencia que el cliente final pueda encontrar. Este artículo plantea que es el Endomárketing una estrategia eficaz para mejorar los procesos organizacionales, la satisfacción de los clientes internos y la proyección empresarial

Endomárketing: Strategy for innovation in organizations in the 21st century

Productividad, rentabilidad y buen clima organizacional son los retos que las empresas, sin importar su tamaño, asumen en este siglo. La competitividad permanente ha generado un ambiente empresarial reñido donde el nivel de engranaje interno de la empresa se refleja en el posicionamiento del producto o servicio que ofrece la misma al cliente final. Es por ello gestionar hacia el interior de las empresas ha tomado relevancia generando procesos innovadores como el Endomárketing. Este es una serie de técnicas dirigidas y aplicadas a los clientes internos (empleados) que crea motivación permanente hacia la realización de sus labores diarias, compromiso y lealtad con la organización, para lograr que el trabajador sea el primer cliente, en el más fiel y la mejor referencia que el cliente final pueda encontrar. Este artículo plantea que es el Endomárketing una estrategia eficaz para mejorar los procesos organizacionales, la satisfacción de los clientes internos y la proyección empresarial.Productivity, profitability and good organizational climate are the challenges that companies, regardless of their size, assume in this century. The permanent competitiveness has generated a tight business environment in the level of internal gear of the company is reflected in the positioning of the product or service that offers the same to the end customer. This is why managing to the interior of companies has taken on a role in generating innovative processes such as Endomarketing. This is a series of techniques directed and applied to the internal customers (employees) that create the permanent motivation towards the accomplishment of their daily tasks, the commitment and the end of the organization, to make the worker the first client, in the more faithful and The best reference that the final customer can find. This article proposes that Endomarketing is an effective strategy to improve organizational processes, internal customer satisfaction and business projection

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

By September 2022, more than 600 million cases of SARS-CoV-2 infection have been reported globally, resulting in over 6.5 million deaths. COVID-19 mortality risk estimators are often, however, developed with small unrepresentative samples and with methodological limitations. It is highly important to develop predictive tools for pulmonary embolism (PE) in COVID-19 patients as one of the most severe preventable complications of COVID-19. Early recognition can help provide life-saving targeted anti-coagulation therapy right at admission. Using a dataset of more than 800,000 COVID-19 patients from an international cohort, we propose a cost-sensitive gradient-boosted machine learning model that predicts occurrence of PE and death at admission. Logistic regression, Cox proportional hazards models, and Shapley values were used to identify key predictors for PE and death. Our prediction model had a test AUROC of 75.9% and 74.2%, and sensitivities of 67.5% and 72.7% for PE and all-cause mortality respectively on a highly diverse and held-out test set. The PE prediction model was also evaluated on patients in UK and Spain separately with test results of 74.5% AUROC, 63.5% sensitivity and 78.9% AUROC, 95.7% sensitivity. Age, sex, region of admission, comorbidities (chronic cardiac and pulmonary disease, dementia, diabetes, hypertension, cancer, obesity, smoking), and symptoms (any, confusion, chest pain, fatigue, headache, fever, muscle or joint pain, shortness of breath) were the most important clinical predictors at admission. Age, overall presence of symptoms, shortness of breath, and hypertension were found to be key predictors for PE using our extreme gradient boosted model. This analysis based on the, until now, largest global dataset for this set of problems can inform hospital prioritisation policy and guide long term clinical research and decision-making for COVID-19 patients globally. Our machine learning model developed from an international cohort can serve to better regulate hospital risk prioritisation of at-risk patients

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Background: COVID-19 is primarily known as a respiratory illness; however, many patients present to hospital without respiratory symptoms. The association between non-respiratory presentations of COVID-19 and outcomes remains unclear. We investigated risk factors and clinical outcomes in patients with no respiratory symptoms (NRS) and respiratory symptoms (RS) at hospital admission. Methods: This study describes clinical features, physiological parameters, and outcomes of hospitalised COVID-19 patients, stratified by the presence or absence of respiratory symptoms at hospital admission. RS patients had one or more of: cough, shortness of breath, sore throat, runny nose or wheezing; while NRS patients did not. Results: Of 178,640 patients in the study, 86.4 % presented with RS, while 13.6 % had NRS. NRS patients were older (median age: NRS: 74 vs RS: 65) and less likely to be admitted to the ICU (NRS: 36.7 % vs RS: 37.5 %). NRS patients had a higher crude in-hospital case-fatality ratio (NRS 41.1 % vs. RS 32.0 %), but a lower risk of death after adjusting for confounders (HR 0.88 [0.83-0.93]). Conclusion: Approximately one in seven COVID-19 patients presented at hospital admission without respiratory symptoms. These patients were older, had lower ICU admission rates, and had a lower risk of in-hospital mortality after adjusting for confounders